Covered recipient · General Payments record
DAVID R SPIGEL
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2024
$162,124.48
- Reported across 258 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,300.00 | 1 |
| Food and Beverage | $1,247.05 | 46 |
| Travel and Lodging | $67.40 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $3,403.70 | 3 |
| Acerta Pharma LLC | $187.61 | 3 |
| Merck Sharp & Dohme Corporation | $133.51 | 5 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $123.98 | 1 |
| Daiichi Sankyo Inc. | $103.14 | 4 |
| EISAI INC. | $54.05 | 2 |
| PFIZER INC. | $48.42 | 3 |
| AVEO Pharmaceuticals, Inc. | $43.88 | 1 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $36.48 | 2 |
| Janssen Biotech, Inc. | $35.92 | 2 |
| Exelixis Inc. | $35.10 | 2 |
| Genentech USA, Inc. | $34.62 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $31.54 | 2 |
| Tempus AI, Inc | $29.57 | 1 |
| Stemline Therapeutics Inc. | $25.51 | 1 |
| Lilly USA, LLC | $23.84 | 1 |
| Gilead Sciences, Inc. | $22.86 | 1 |
| Deciphera Pharmaceuticals Inc. | $22.34 | 1 |
| Verity Pharmaceuticals Inc. | $21.32 | 1 |
| EMD Serono, Inc. | $21.12 | 1 |
| SERVIER PHARMACEUTICALS LLC | $20.49 | 1 |
| JAZZ PHARMACEUTICALS INC. | $19.33 | 1 |
| Celgene Corporation | $18.87 | 1 |
| ARRAY BIOPHARMA INC | $18.36 | 1 |
| TerSera Therapeutics LLC | $18.23 | 1 |
| Astellas Pharma US Inc | $17.22 | 1 |
| AstraZeneca UK Limited | $16.90 | 1 |
| Mirati Therapeutics, Inc. | $16.58 | 1 |
| SOBI, INC | $16.16 | 1 |
| Sumitomo Pharma America, Inc. | $13.80 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (49)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.